Abstract:
:Adler et al., in a paper appearing in Nature Genetics, exploited the intersect of genetic information from expression profiles with that from array comparative genomic hybridization in human breast cancers to identify genes that may induce the transcription of the prognostic "wound response" expression signature. The amplification of two genes, MYC and CSN5, appeared to be correlated with the wound response cassette. In vitro validation showed that the wound signature could be induced in MCF10A cells only when MYC and CSN5 were coexpressed. This work shows that the intersect analysis of gene amplification and transcriptional expression on a genome-wide scale can uncover complex conditional interactions embedded in the systems map of transcriptional regulation.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Liu ET,Kuznetsov VA,Miller LDdoi
10.1016/j.ccr.2006.03.026subject
Has Abstractpub_date
2006-04-01 00:00:00pages
245-7issue
4eissn
1535-6108issn
1878-3686pii
S1535-6108(06)00092-4journal_volume
9pub_type
杂志文章,评审相关文献
CANCER CELL文献大全abstract::The MAP3-kinase TGF-beta-activated kinase 1 (TAK1) critically modulates innate and adaptive immune responses and connects cytokine stimulation with activation of inflammatory signaling pathways. Here, we report that conditional ablation of TAK1 in liver parenchymal cells (hepatocytes and cholangiocytes) causes hepatoc...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2010.03.021
更新日期:2010-05-18 00:00:00
abstract::Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into ...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2019.07.010
更新日期:2019-09-16 00:00:00
abstract::Recent evidence suggests that human cells require more genetic changes for neoplastic transformation than do their murine counterparts. However, a precise enumeration of these differences has never been undertaken. We have determined that perturbation of two signaling pathways-involving p53 and Raf-suffices for the tu...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2004.07.009
更新日期:2004-08-01 00:00:00
abstract::Neuroblastoma, an embryonal cancer of neural crest origin, shows metastases frequently at diagnosis. In this issue of Cancer Cell, Delloye-Bourgeois and colleagues demonstrate that neuroblastoma cell lines and patient-derived xenografts engraft and adopt a metastatic program in chick embryos. They identify Sema3C as a...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2017.09.012
更新日期:2017-10-09 00:00:00
abstract::We report that mouse LSL-KrasG12D;Trp53fl/fl (KP)-mediated lung adenocarcinoma (LADC) tumorigenesis can proceed through both PKCι-dependent and PKCι-independent pathways. The predominant pathway involves PKCι-dependent transformation of bronchoalveolar stem cells (BASCs). However, KP mice harboring conditional knock o...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2019.07.002
更新日期:2019-08-12 00:00:00
abstract::Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage response (DDR). In contrast, Myc activation-although producing a DDR as well-is known to primarily elicit an apoptotic countermeasure. Using the Emu-my...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2009.12.043
更新日期:2010-03-16 00:00:00
abstract::A definitive knockout reported in this issue of Cancer Cell by Sicinska et al. reveals an unsuspected role for cyclin D3 in normal T cell development and suggests new therapeutic possibilities in precursor T cell leukemia. ...
journal_title:Cancer cell
pub_type: 评论,杂志文章,评审
doi:10.1016/s1535-6108(03)00305-2
更新日期:2003-12-01 00:00:00
abstract::Cancer-associated chromosomal translocations create chimeric oncoproteins that contribute to aberrant growth by dominant or dominant negative mechanisms. Interestingly, genes such as MLL, RARA, and EWS are fused to multiple partners. This molecular promiscuity can provide important functional information, as specific ...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/s1535-6108(04)00060-1
更新日期:2004-03-01 00:00:00
abstract::Emerging strategies in cancer therapeutics link the genomic mutational and proteomic landscape, allowing intelligent reasoning on target selection. In this issue of Cancer Cell, Piccinin and colleagues use this approach to demonstrate that the mesenchymal protein Twist1 inhibits p53, providing a novel target for react...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2012.08.020
更新日期:2012-09-11 00:00:00
abstract::Oncoproteins and tumor suppressors antagonistically converge on critical nodes governing neoplastic growth, invasion, and metastasis. We discovered that phosphorylation of the ETS1 and ETS2 transcriptional oncoproteins at specific serine or threonine residues creates binding sites for the COP1 tumor suppressor protein...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2014.06.026
更新日期:2014-08-11 00:00:00
abstract::Immune checkpoint-blockade treatments targeting PD-1/PD-L1 have revolutionized cancer therapy. Hence, understanding the regulation of PD-L1 expression has major clinical relevance. In this issue of Cancer Cell, Lim et al. report that inflammation-induced and NF-κB-driven expression of deubiquitinating enzyme CSN5 lead...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2016.11.013
更新日期:2016-12-12 00:00:00
abstract::Our understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has been limited by a lack of knowledge regarding the tumor cell of origin. To circumvent this, we analyzed the function of EWS/FLI in Ewing's sarcoma itself. By combining retroviral-mediated RNA interference with reexpression stud...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2006.04.004
更新日期:2006-05-01 00:00:00
abstract::In a recent issue of Cell, Kumar and colleagues uncovered a synthetic lethal interaction between oncogenic KRAS and the transcription factor GATA2 in non-small cell lung carcinoma. Pharmacological inhibition of GATA2-mediated pathways with bortezomib and fasudil results in dramatic tumor inhibition. These observations...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2012.04.032
更新日期:2012-05-15 00:00:00
abstract::The Twist1 transcription factor is known to promote tumor metastasis and induce Epithelial-Mesenchymal Transition (EMT). Here, we report that Twist1 is capable of promoting the formation of invadopodia, specialized membrane protrusions for extracellular matrix degradation. Twist1 induces PDGFRα expression, which in tu...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2011.01.036
更新日期:2011-03-08 00:00:00
abstract::To identify FDA-approved agents targeting leukemic cells, we performed a chemical screen on two human leukemic cell lines and identified the antimicrobial tigecycline. A genome-wide screen in yeast identified mitochondrial translation inhibition as the mechanism of tigecycline-mediated lethality. Tigecycline selective...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2011.10.015
更新日期:2011-11-15 00:00:00
abstract::Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differenti...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2012.06.027
更新日期:2012-08-14 00:00:00
abstract::Single-cell sequencing (SCS) has impacted many areas of cancer research and improved our understanding of intratumor heterogeneity, the tumor microenvironment, metastasis, and therapeutic resistance. The development and refinement of SCS technologies has led to massive reductions in costs, increased cell throughput, a...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2020.03.008
更新日期:2020-04-13 00:00:00
abstract::Aneuploidy is a hallmark of cancer, although its effects on tumorigenesis are unclear. Here, we investigated the relationship between aneuploidy and cancer development using cells engineered to harbor single extra chromosomes. We found that nearly all trisomic cell lines grew poorly in vitro and as xenografts, relativ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2016.12.004
更新日期:2017-02-13 00:00:00
abstract::The transcription factor Meis1 drives myeloid leukemogenesis in the context of Hox gene overexpression but is currently considered undruggable. We therefore investigated whether myeloid progenitor cells transformed by Hoxa9 and Meis1 become addicted to targetable signaling pathways. A comprehensive (phospho)proteomic ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2017.03.001
更新日期:2017-04-10 00:00:00
abstract::How loss-of-function of GATA3 contributes to the development of breast cancer is poorly understood. Here, we report that GATA3 nucleates a transcription repression program composed of G9A and MTA3-, but not MTA1- or MTA2-, constituted NuRD complex. Genome-wide analysis of the GATA3/G9A/NuRD(MTA3) targets identified a ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2015.04.011
更新日期:2015-06-08 00:00:00
abstract::It is established that p38 MAPK can negatively regulate tumorigenesis, but the mechanism is incompletely understood. A new study in this issue of Cancer Cell shows that p38 MAP kinase plays a selective role in tumor initiation mediated by oxidative stress. ...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2007.01.009
更新日期:2007-02-01 00:00:00
abstract::The proapoptotic death receptor DR5 has been studied extensively in cancer cells, but its action in the tumor microenvironment is not well defined. Here, we uncover a role for DR5 signaling in tumor endothelial cells (ECs). We detected DR5 expression in ECs within tumors but not normal tissues. Treatment of tumor-bear...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2012.05.014
更新日期:2012-07-10 00:00:00
abstract::Inhibition of ERK-MAPK signaling by expression of dominant-negative MEK1 in the tumor vasculature suppresses angiogenesis and tumor growth. In an organotypic tissue culture angiogenesis assay, ERK-MAPK inhibition during the migratory phase results in loss of bipolarity, detachment, and cell death of isolated endotheli...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2005.12.021
更新日期:2006-01-01 00:00:00
abstract::Metastases arising from tumors have the proclivity to colonize specific organs, suggesting that they must rewire their biology to meet the demands of the organ colonized, thus altering their primary properties. Each metastatic site presents distinct metabolic challenges to a colonizing cancer cell, ranging from fuel a...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2018.02.001
更新日期:2018-03-12 00:00:00
abstract::Genome-wide cancer mutation analyses are revealing an extensive landscape of functional mutations within the noncoding genome, with profound effects on the expression of long noncoding RNAs (lncRNAs). While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, we now underst...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccell.2016.03.010
更新日期:2016-04-11 00:00:00
abstract::Homeotic (HOX) genes are dysregulated in multiple malignancies, including several AML subtypes. We demonstrate that H3K79 dimethylation (H3K79me2) is converted to monomethylation (H3K79me1) at HOX loci as hematopoietic cells mature, thus coinciding with a decrease in HOX gene expression. We show that H3K79 methyltrans...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2014.10.009
更新日期:2014-12-08 00:00:00
abstract::Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives many of the cancer "hallmarks" through downstream activation of the gp130/STAT3 signaling pathway. However, we show that the related cytokine IL-11 has a stronger correlation with elevated STAT3 activation in human gastrointestinal...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2013.06.017
更新日期:2013-08-12 00:00:00
abstract::Rapamycin analogs that inhibit mTOR signaling have antitumor activity against certain lymphomas, but treatment of solid tumors has been less encouraging despite inhibition of mTOR function. Two recent papers give insight into the potential use of mTOR inhibitors. O'Reilly et al. provide evidence that poor tumor respon...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/j.ccr.2006.02.027
更新日期:2006-03-01 00:00:00
abstract::MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single nucleotide polymorphism (SNP) in the human MDM2 promoter increases the affinity of Sp1 resulting in elevated MDM2 levels. We generated mice carrying either the MDM2(SNP309T) or the MDM2(SNP309G) allele to address the imp...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2010.07.010
更新日期:2010-09-14 00:00:00
abstract::The TFAP2C/AP-2γ transcription factor regulates luminal breast cancer genes, and loss of TFAP2C induces epithelial-mesenchymal transition. By contrast, the highly homologous family member, TFAP2A, lacks transcriptional activity at luminal gene promoters. A detailed structure-function analysis identified that sumoylati...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2014.04.008
更新日期:2014-06-16 00:00:00